This year’s ASMS conference in Baltimore brought together scientists and industry partners from around the world to share ideas, new technologies, and research trends. For the biocrates team, it was an exciting week filled with great conversations and new connections. The highlights were the launch of the next generation MxP® Quant 1000 kit and the announcement that biocrates is joining the Bruker Corporation. Many were excited and curious when our kits will run on Bruker platforms. We’re excited too – and we’re working on it. Of course, there were also questions and concerns about this change. biocrates continues to remain dedicated to multi-vendor compatibility as part of the long-term growth strategy together with Bruker.
Our week was shaped by the launch of the new MxP® Quant 1000 kit. There was high traffic and interest on Quant 1000 at our booth. Visitors liked the modularity of the kit – you can run just the small molecules, just the lipids, or both. The small-molecule panel (MxQuant) was especially popular. Our breakfast seminar which showed off the new kit as well as the first study was well attended and brought in great feedback.
Key takeaways
A clear trend this year was the combination of targeted and untargeted metabolomics. Many researchers are now using high-resolution platforms to switch between discovery and quantification. Another major theme was multiomics – combining metabolomics with other data layers like proteomics and genomics to enable a more complete understanding of biological systems. Multiomics can uncover complex interactions that would be missed by studying just one type of omics data. We also saw growing interest in exposomics, especially in understanding endogenous metabolism and systemic response to environmental exposures like pesticides or chemicals. Also here the field is shifting from broad discovery to more focused, targeted analysis.
While there were fewer major instrument launches this year, software solutions, AI-assisted data analysis and automation tools were everywhere. Labs are clearly looking for easier, faster, and more reliable ways to work with large amounts of data. We were proud to see our WebIDQ platform mentioned by others as a strong solution for managing metabolomics data obtained by our kits.
We also spoke with many scientists new to metabolomics, often coming from proteomics, who were excited to explore our standardized kit solutions. Some of our users told us they had tested other kits, but preferred to stay with biocrates. They value the quality and ready-to-use components, our advanced software and complete workflow automation, and especially our exceptional customer support.
Despite a hiccup with our booth materials being delayed at customs, our North American team made it all work. Thanks to their dedication, we had everything we needed to connect with the ASMS community.
In the end, ASMS 2025 reminded us why we do what we do. It’s about advancing science, meeting passionate people, and working together to solve complex problems. Thanks to everyone who stopped by – we’re already looking forward to seeing you next year in San Diego.
